Skip to main content
    G

    Gain Therapeutics Inc (GANX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.18
    +0.24 (+25.51%)

    Market Cap: $46.31M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Gain Therapeutics Inc (GANX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Gain Therapeutics (GANX) has a latest price of $1.18 on Nov 17, 2026, 72.8% below its 52-week high of $4.34. Its price fell 58.3% over the past 12 months. The month-end price fell 83.8% over the 5 years through Oct 2026, a compound annual decline of 30.5%.

    Price Chart

    From Mar 2021 to Oct 2026, its highest month-end close was $14.92 in Mar 2021 and its lowest $1.08 in Jul 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GANX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GANX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 43.0%, and over 6 months it fell 25.8%. The month-end price fell 60.5% over the 3 years through Oct 2026, a compound annual decline of 26.6%.

    PeriodChange
    1 month-5.6%
    3 months-43.0%
    6 months-25.8%
    12 months-58.3%
    12 months, with dividends-58.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-60.5%-26.6%
    5 years-83.8%-30.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 49.1%, and its weakest was 2022, when it fell 42.4%.

    YearCloseChange
    2026 through Oct 2026$1.13-64.9%
    2025$3.22+49.1%
    2024$2.16-33.8%
    2023$3.27+4.3%
    2022$3.13-42.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 17.9% below its 50-day average of $1.44 and 34.7% below its 200-day average of $1.81.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.18
    52-week high$4.34-72.8%
    52-week low$0.94+25.5%
    50-day average$1.44-17.9%
    200-day average$1.81-34.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 81.4%.

    MeasureValue
    1-year beta1.64
    Largest fall, 1 year-77.5%
    Largest fall, 3 years-81.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GANX

    What is GANX's 1-year price change?

    Gain Therapeutics's price fell 58.3% over the past 12 months. With dividends included, the 12-month total return was -58.3%.

    What is GANX's 5-year price change?

    Gain Therapeutics's month-end price fell 83.8% over the 5 years through Oct 2026, a compound annual decline of 30.5%. These figures leave out dividends.

    What is GANX's 52-week high and low?

    Gain Therapeutics's 52-week high is $4.34 and its 52-week low is $0.94. Its latest price of $1.18 on Nov 17, 2026 is 72.8% below the high.

    What is GANX's beta?

    Gain Therapeutics's 1-year beta against the S&P 500 is 1.64, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.5%.

    Is the GANX chart free?

    Yes. Advanced Charting for GANX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.